ASF-1096 regulatory update

EMEA's Committee for Orphan Medical Products (COMP) granted Orphan Drug designation for Astion's ASF-1096 to treat cutaneous lupus erythematosus. The 0.5% cream formulation of the R-enantiomer of salb...